Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 7/20 | 0.50 |
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | CA9 | Q16790 | 6/20 | 0.50 |
| ▸ | CA12 | O43570 | 5/20 | 0.50 |
| ▸ | CA7 | P43166 | 5/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.50 |
| ▸ | CA4 | P22748 | 4/20 | 0.50 |
| ▸ | CA6 | P23280 | 4/20 | 0.50 |
| ▸ | CA5A | P35218 | 4/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.50 |
| ▸ | CA3 | P07451 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | CASP1 | P29466 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516458 | 1.00 | GAA (0.52) | GAACA1CA2CA9CA12 | |
| SCHEMBL11284960 | 0.98 | GAA (0.50) | GAACA1CA2CA9CA12 | |
| Hydrochloric Acid SCHEMBL11242082 | 0.98 | GAA (0.50) | GAACA1CA2CA9CA12 | |
| SCHEMBL11284975 | 0.98 | GAA (0.50) | GAACA1CA2CA9CA12 | |
| Nitrogen SCHEMBL11697308 | 0.96 | GAA (0.48) | GAACA1CA2CA9CA12 | |
| SCHEMBL9128043 | 0.91 | ALDH1A1 (0.48) | GAACA1CA2CA9CA12 | |
| SCHEMBL9327134 | 0.89 | ALDH1A1 (0.50) | GAACA1CA2CA9CA12 | |
| SCHEMBL9636203 | 0.88 | ALDH1A1 (0.43) | GAACA1CA2CA9CA12 | |
| SCHEMBL9327065 | 0.87 | CA1 (0.61) | GAACA1CA2CA9CA12 | |
| SCHEMBL8100236 | 0.87 | ALDH1A1 (0.48) | GAACA1CA2CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107827821-B | Continuous flow clean production process of pyrazolone series products | 南通醋酸化工股份有限公司 | 2021-01-26 | — | — | CN | claimed |
| EP-0429614-B1 | AZOPHENYL COMPOUNDS | JAMES ROBINSON LTD (GB) | 1995-10-11 | — | — | EP | claimed |
| WO-1990015850-A1 | AZOPHENYL COMPOUNDS | JAMES ROBINSON LIMITED (GB) | 1990-12-27 | — | — | WO | claimed |
| US-4067923-A | Process for producing isoprene | BELYAEV VLADIMIR ALEXANDROVICH | 1978-01-10 | — | — | US | claimed |
| EP-4653870-A1 | METHOD AND REAGENT FOR QUANTIFYING PROTEIN | Nitto Boseki Co., Ltd. (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-20250221408-A1 | COMPOSITION | EARTH CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| CN-120153260-A | Method and reagent for quantifying protein | 日东纺绩株式会社 | 2025-06-13 | — | — | CN | disclosed |
| EP-4473837-A1 | COMPOSITION | Earth Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| WO-2024154593-A1 | METHOD AND REAGENT FOR QUANTIFYING PROTEIN | 日東紡績株式会社 | 2024-07-25 | — | — | WO | disclosed |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-117281115-A | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2023-12-26 | — | — | CN | disclosed |
| WO-2023190598-A1 | COMPOSITION | アース製薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-4020053-A | Phenylazo-(N-alkylanilino)-m-toluene sulfonic acid or sulfonamide acid dyes for polyamide fiber materials | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
| US-4014866-A | FOR SURFACE COATINGS, PRINTING INKS AND RESINS | BASF AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
| US-3995993-A | Process for the differential dyeing of polyamide fibers and of materials containing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-12-07 | — | — | US | disclosed |
| US-3979378-A | Water-soluble azo dyes having a substituted 2-hydroxypyridone (6) coupling component | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-09-07 | — | — | US | disclosed |
| US-3957728-A | MODIFIED WITH S-TRIAZINES; ABSORBENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
| US-3947407-A | ANTHRAQUINONE DYE | CIBA-GEIGY AG (CH) | 1976-03-30 | — | — | US | disclosed |
| US-3933423-A | Azoic dyeing of leather | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932378-A | Sulfonated disazo dyestuffs containing an ether group | CIBA-GEIGY AG (CH) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | GAA 390/4885CA1 3911/4885CA2 2225/4885 |
| US-20250221408-A1 | COMPOSITION | GGPS1, PGGT1B, HBG2 | GAA 3820/4885CA1 2324/4885CA2 2673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.